Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kaleido Biosciences goes public netting $69.8mm

Executive Summary

Kaleido Biosciences Inc. netted $69.8mm in its initial public offering of 5mm common shares at $15 each on the Nasdaq. The company had planned to sell 4.76mm shares between $20 and $22.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies